B. Braun CeGaT Surpasses Milestone of 1,000 Patient Samples Tested for Neuromuscular and 500 for Neurodegenerative Diseases; Will Introduce Comprehensive Genomic Testing Services for Neurodegenerative Diseases at the 2015 Am